Predicting the time in therapeutic range in patients with atrial fibrillation: validation of the SAMe-TT2R2 score in a Hispanic cohort.

Back

ESC Premium Access

Predicting the time in therapeutic range in patients with atrial fibrillation: validation of the SAMe-TT2R2 score in a Hispanic cohort.

Session: Poster session 3 - Drug treatment

Topic: Antiarrhythmic drugs

Speaker: Doctor A. Rueda Linares (Madrid, ES)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Doctor Andrea Rueda Linares

Gomez Ulla Central Defense Hospital, Madrid (Spain)

0 follower

24 more presentations in this session

Impact of digoxin use on adverse outcomes in patients with atrial fibrillation: results from a multicenter atrial fibrillation registry study in China

Speaker: Miss S. Wu (Beijing, CN)

Access

Abstract

Slides

Rate-control treatment and clinical outcomes in patients with atrial fibrillation and obstructive lung disease

Speaker: Doctor S. You (Seoul, KR)

Access

Abstract

Slides

Efficacy of acute intravenous therapy with potassium, magnesium and metoprolol in recent-onset atrial fibrillation

Speaker: Miss A. Moser (Hamburg, DE)

Access

Abstract

Postoperative atrial fibrillation in patients with reduced ejection fraction heart failure undergoing cardiac surgery: ranolazine shortens time to conversion when added to amiodarone

Speaker: Professor J. Skoularigis (Larissa, GR)

Access

Abstract

Slides

INR prior to bleeding is below 3.0 most of the time in patients with atrial fibrillation using warfarin

Speaker: Doctor P. Oliveira Guimaraes (Durham, US)

Access

Abstract

Slides

Access the full session

Poster session 3 - Drug treatment

Speakers: Doctor A. Rueda Linares, Miss S. Wu, Doctor S. You, Miss A. Moser, Professor J. Skoularigis...

Access

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources